Alterity Therapeutics (ATHE) Exchange Rate Effect (2010 - 2020)
Alterity Therapeutics (ATHE) posted Exchange Rate Effect of -$172360.6 for Q2 2020, down 297.37% on a QoQ basis from $87328.6 in Q4 2019, and up 39.07% year-over-year from -$123933.5 in Q3 2019.
Analysis
Alterity Therapeutics (ATHE) Exchange Rate Effect (2010 - 2020) Analysis & Trends
Alterity Therapeutics has reported Exchange Rate Effect for 7 years, with the latest figure at -$172360.6 in Q2 2020.
- On a quarterly basis, Exchange Rate Effect rose 39.07% year-over-year to -$172360.6 in Q2 2020; TTM through Jun 2020 was -$203082.4, a 97.03% increase from a year earlier, with the FY2026 full-year figure at $36582.8, up 128.79% from the prior year.
- Exchange Rate Effect was -$172360.6 for Q2 2020 at Alterity Therapeutics, down from $87328.6 in the prior quarter.
- The five-year high for Exchange Rate Effect was $164855.6 in Q4 2018, with the low at -$6.3 million in Q2 2018.
- Average Exchange Rate Effect over 4 years is -$1.8 million, with a median of -$282906.0 recorded in 2019.
- The sharpest annual moves came in 2018 and 2019: Exchange Rate Effect soared 135.15% in 2018, then sank 47.03% in 2019.
- Over 4 years, Exchange Rate Effect stood at -$469062.8 in 2017, then jumped by 135.15% to $164855.6 in 2018, then tumbled by 47.03% to $87328.6 in 2019, then sank by 297.37% to -$172360.6 in 2020.
- The last three Exchange Rate Effect figures came in at -$172360.6 (Q2 2020), $87328.6 (Q4 2019), and -$282906.0 (Q2 2019), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 315,000.00 |
| 10 | Alterity Therapeutics | 72.80 Mn | 72.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2020 | -172,360.55 |
| Dec 31, 2019 | 87,328.62 |
| Jun 30, 2019 | -282,906.04 |
| Dec 31, 2018 | 164,855.57 |
| Jun 30, 2018 | -6.26 Mn |
| Dec 31, 2017 | -469,062.76 |
| Jun 30, 2017 | -5.67 Mn |
| Dec 31, 2012 | -157,074.59 |
| Dec 31, 2011 | 11,333.87 |
| Dec 31, 2010 | 7.55 Mn |